172 related articles for article (PubMed ID: 10403560)
1. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes.
Mundle SD; Reza S; Ali A; Mativi Y; Shetty V; Venugopal P; Gregory SA; Raza A
Cancer Lett; 1999 Jun; 140(1-2):201-7. PubMed ID: 10403560
[TBL] [Abstract][Full Text] [Related]
2. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes.
Mundle SD; Ali A; Cartlidge JD; Reza S; Alvi S; Showel MM; Mativi BY; Shetty VT; Venugopal P; Gregory SA; Raza A
Am J Hematol; 1999 Jan; 60(1):36-47. PubMed ID: 9883804
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
[TBL] [Abstract][Full Text] [Related]
4. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
[TBL] [Abstract][Full Text] [Related]
5. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes.
Mundle SD; Venugopal P; Cartlidge JD; Pandav DV; Broady-Robinson L; Gezer S; Robin EL; Rifkin SR; Klein M; Alston DE; Hernandez BM; Rosi D; Alvi S; Shetty VT; Gregory SA; Raza A
Blood; 1996 Oct; 88(7):2640-7. PubMed ID: 8839858
[TBL] [Abstract][Full Text] [Related]
6. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes.
Ali A; Mundle SD; Ragasa D; Reza S; Shetty V; Mativi BY; Cartlidge JD; Azharuddin M; Qawi H; Dar S; Raza A
J Hematother Stem Cell Res; 1999 Aug; 8(4):343-56. PubMed ID: 10634172
[TBL] [Abstract][Full Text] [Related]
7. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
Saberwal G; Broderick E; Janssen I; Shetty V; Alvi S; Lisak L; Venugopal P; Raza A; Mundle SD
J Hematother Stem Cell Res; 2003 Aug; 12(4):443-50. PubMed ID: 12965081
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.
Arimura K; Arima N; Matsushita K; Ohtsubo H; Fujiwara H; Kukita T; Ozaki A; Hagiwara T; Hamada H; Yoshino K; Tei C
Eur J Haematol; 2004 Jul; 73(1):17-24. PubMed ID: 15182333
[TBL] [Abstract][Full Text] [Related]
10. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
11. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
12. A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.
Peng H; Wen J; Zhang L; Li H; Chang CC; Zu Y; Zhou X
Mol Biosyst; 2012 Apr; 8(4):1366-74. PubMed ID: 22327869
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
[TBL] [Abstract][Full Text] [Related]
15. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.
Shetty V; Mundle S; Alvi S; Showel M; Broady-Robinson L; Dar S; Borok R; Showel J; Gregory S; Rifkin S; Gezer S; Parcharidou A; Venugopal P; Shah R; Hernandez B; Klein M; Alston D; Robin E; Dominquez C; Raza A
Leuk Res; 1996; 20(11-12):891-900. PubMed ID: 9009245
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32).
Suzuki Y; Farbman AI
Exp Neurol; 2000 Sep; 165(1):35-45. PubMed ID: 10964483
[TBL] [Abstract][Full Text] [Related]
17. Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Benesch M; Platzbecker U; Ward J; Deeg HJ; Leisenring W
Leukemia; 2003 Dec; 17(12):2460-6. PubMed ID: 14562111
[TBL] [Abstract][Full Text] [Related]
18. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes.
Boudard D; Sordet O; Vasselon C; Revol V; Berthéas MF; Freyssenet D; Viallet A; Piselli S; Guyotat D; Campos L
Leukemia; 2000 Dec; 14(12):2045-51. PubMed ID: 11187891
[TBL] [Abstract][Full Text] [Related]
19. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation.
Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z
Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603
[TBL] [Abstract][Full Text] [Related]
20. Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates.
Shetty V; Hussaini S; Broady-Robinson L; Allampallam K; Mundle S; Borok R; Broderick E; Mazzoran L; Zorat F; Raza A
Blood; 2000 Aug; 96(4):1388-92. PubMed ID: 10942382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
